Clinical Trials

Showing 361 - 380 of 449 trials
Titlesort icon Investigator Disease(s)
A Study of the Biologic Effects of BMS-936558 in Patients with Inoperable or Metastatic Melanoma
[Protocol 12-231]
Wolchok, Jedd
  • Melanoma
A Study of Vorinostat (SAHA) plus Isotretinoin and Chemotherapy in Infants and Young Children with Embryonal Tumors of the Central Nervous System
[Protocol 12-191]
Kramer, Kim
  • Pediatric Brain Tumors
    • Brain Cancer
A Survey of Psychosocial Needs and Exploration of Online Support for Patients with Pleural Mesothelioma
[Protocol 11-066]
Key, Richard
  • Mesothelioma
A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma
[Protocol 09-171]
Landau, Heather
  • Blood & Marrow Stem Cell Transplantation
    • Autologous
    • Sibling and Unrelated Volunteer
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Multiple Myeloma
Acupuncture for Chronic Lymphedema After Breast Cancer Treatment
[Protocol 12-210]
Cassileth, Barrie
  • Breast Cancer
  • Survivorship
Adherence to Comprehensive, Multi-Organ Screening Recommendations in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients
[Protocol 04-144]
Stadler, Zsofia
  • Colorectal Cancer
    • Colon Cancer
  • Hereditary Cancer & Genetics
  • Psychiatry & Behavioral Sciences
Adolescent and Young Adult Cancer Survivors: Identity Development
[Protocol 09-001]
Ford, Jennifer
  • Survivorship
Adoptive Transfer of Autologous T Cells Targeted to Prostate-Specific Membrane Antigen for the Treatment Of Castrate Metastatic Prostate Cancer
[Protocol 09-036]
Slovin, Susan
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
ALTE03N1: Key Adverse Events Following Childhood Cancer
[Protocol 05-070]
Sklar, Charles
  • Survivorship
An Evaluation of Perceptions and Quality of Life Among Patients Receiving Ipilimumab for Melanoma
[Protocol 11-184]
Hay, Jennifer
  • Melanoma
An Interactive e-Health Program to Promote Health Behaviors Among Cancer Survivors
[Protocol 12-090]
Ostroff, Jamie
  • Breast Cancer
  • Prostate Cancer
    • Quality of Life
  • Survivorship
Analysis of Blood and Salivary Samples for Genetic Studies of Familial Cancers
[Protocol 93-102]
Offit, Kenneth
  • Hereditary Cancer & Genetics
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
[Protocol 00-069]
Offit, Kenneth
  • Hereditary Cancer & Genetics
  • Leukemia
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
Assessment of a Customized Computer Program for Reducing Fears of Breast Cancer Recurrence
[Protocol 11-204]
Lichtenthal, Wendy
  • Breast Cancer
  • Psychiatry & Behavioral Sciences
  • Survivorship
Biomarkers of Molecular Risk in Smokers
[Protocol 04-141]
Boyle, Jay
Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLA-Compatible Donor
[Protocol 12-053]
O'Reilly, Richard
  • Blood & Marrow Stem Cell Transplantation
  • Hematology
    • Hematologic Disorders
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Non-Hodgkin's Lymphoma
Brentuximab (SGN-35) in Transplant-Eligible Patients with Relapsed or Refractory Hodgkin Lymphoma
[Protocol 11-142]
Moskowitz, Alison
  • Lymphoma
    • Hodgkin's Disease
Chemotherapy Alone or with Radiation Therapy for Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery
[Protocol 12-087]
Saltz, Leonard
  • Colorectal Cancer
    • Rectal Cancer
Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
[Protocol 12-104]
Tew, William
  • Geriatrics
  • Ovarian Cancer
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
[Protocol 12-089]
Tew, William
  • Breast Cancer
  • Geriatrics